Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk

CONCLUSIONS: Overall stroke risk in our cohort of CHC users was low. When CHCs are used in those with migraine, formulations containing ≤30 μg EE are preferred. Shared decision-making should include discussions about ischemic stroke risks in patients with migraine, even those without aura.PMID:36752588 | DOI:10.1111/head.14473

https://pubmed.ncbi.nlm.nih.gov/36752588/?utm_source=no_user_agent&utm_medium=rs...

Source: Headache - February 8, 2023 Category: Neurology Authors: Pelin Batur Meng Yao Julia Bucklan Payal Soni Aarushi Suneja Ruth Farrell Maryann Mays Source Type: research